Brody Belt - Alternative Method of Securing a Patient's Urinary Drainage Bag
NCT01228864 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 12
Last updated 2017-12-08
Summary
The Brody belt may help improve quality of life in patients using urinary drainage bags. PURPOSE: This clinical trial studies the Brody belt in improving the quality of life in patients using urinary drainage bags.
Conditions
- Quality of Life
Interventions
- PROCEDURE
-
quality of life
survey
- PROCEDURE
-
Quality of life
Sponsors & Collaborators
-
Roswell Park Cancer Institute
lead OTHER
Principal Investigators
-
Khurshid Guru, MD · Roswell Park Cancer Institute
Study Design
- Allocation
- RANDOMIZED
- Purpose
- SUPPORTIVE_CARE
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2009-09-22
- Primary Completion
- 2017-08-15
- Completion
- 2017-08-15
Countries
- United States
Study Locations
More Related Trials
-
Role of rhPSMA-7.3 PET/CT Imaging in Men With High-Risk Prostate Cancer Following Conventional Imaging and Associated Changes in Medical Management
NCT05799248 ·Status: RECRUITING ·Phase: PHASE3
-
Urolift Pre-SBRT for Reduced Urinary Toxicity in Patients With BPH and Prostate Cancer.
NCT05148156 ·Status: SUSPENDED ·Phase: NA
-
High-dose Brachytherapy Boost With Stereostatic Body Radiation Therapy to Intermediate or Higher Risk Prostate Cancer
NCT05754580 ·Status: RECRUITING ·Phase: NA
-
MRI-guided Brachytherapy and Salvage SBRT Program
NCT07132671 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
PSMA-PET for Biopsy and Treatment Guidance in Primary Prostate Cancer
NCT03429244 ·Status: COMPLETED ·Phase: PHASE2
-
Expanded Access Protocol of 68Ga-PSMA-11 for PET Imaging
NCT04348682 ·Status: APPROVED_FOR_MARKETING
-
Fairly Brief Androgen Suppression and Stereotactic Radiotherapy for High Risk Prostate Cancer - Protocol 2
NCT02229734 ·Status: COMPLETED ·Phase: PHASE2
-
Dose Escalation Study of Preoperative SBRT for High Risk Prostate Cancer
NCT02572284 ·Status: COMPLETED ·Phase: PHASE1
-
Magnetic Resonance Whole Body Diffusion-Weighted Imaging in Finding Bone or Lymph Node Metastasis in Participants With High-Risk Prostate Cancer
NCT03085043 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Brachytherapy for Prostatic Carcinoma Patients
NCT00525720 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
68Ga-PSMA-11 PET/CT for the Diagnosis of Bone Metastases in Patients With Prostate Cancer and Biochemical Progression During Androgen Deprivation Therapy
NCT04928820 ·Status: TERMINATED ·Phase: PHASE2
-
Clinical Utility of ClarityDX Prostate
NCT06678828 ·Status: RECRUITING ·Phase: NA
-
DAPROCA Pelvic Lymph Node Irradiation to Prostate for High Risk Prostate Cancer: Phase I/II Study
NCT01417676 ·Status: COMPLETED ·Phase: NA
-
Efficacy of Ra-223 in PSMA PET Optimally Selected Patients
NCT05924672 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Semi-automatic Download of Prostate Biopsy Cores While Keeping the Orientation, Unfolding and Unity of the Sample
NCT01692405 ·Status: COMPLETED ·Phase: NA
-
LDR vs. HDR Brachytherapy for Prostate Cancer
NCT03426748 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
In Vivo Dosimetry During Prostate Cancer Radiotherapy
NCT01307852 ·Status: COMPLETED ·Phase: PHASE1
-
Using Magnetic Resonance Imaging (MRI) to Guide Differential-Dose Prostate Brachytherapy
NCT01913197 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Validation of the Prostate Cancer Assay - Beta+Pivotal
NCT02742259 ·Status: WITHDRAWN
-
CombIning advaNces in imagiNg With biOmarkers for improVed Diagnosis of Aggressive prosTate cancEr
NCT02689271 ·Status: COMPLETED
-
Evaluation of the Safety and Efficacy of the BioProtect Balloon in Prostate Cancer Subjects Undergoing Radiotherapy
NCT00462124 ·Status: COMPLETED ·Phase: NA
-
Partial Prostate Salvage High Dose Rate Brachytherapy
NCT03246802 ·Status: RECRUITING ·Phase: NA
-
Comparative Study of Radiotherapy Treatments to Treat High Risk Prostate Cancer Patients
NCT02303327 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Ga-68 MAA Distribution in PAE Patients
NCT04243824 ·Status: WITHDRAWN ·Phase: EARLY_PHASE1
-
The Role of 68Gallium PSMA-11 in Enhancing Diagnosis of Primary and Metastatic Prostate Cancer
NCT04179968 ·Status: COMPLETED ·Phase: PHASE2